Cg Oncology
(NASDAQ) CGON
Cg Oncology Financials at a Glance
Market Cap
$5.80B
Revenue (TTM)
$5.07M
Net Income (TTM)
-$186.75M
EPS (TTM)
-$2.34
P/E Ratio
-28.06
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Price
$70.37
Volume
452,117.946
Open
$65.47
Price
$70.37
Volume
452,117.946
Open
$65.47
Previous Close
$65.73
Daily Range
$65.03 - $71.25
52-Week Range
$23.65 - $75.50
Estimated Earnings Date
May 7, 2026
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Price
$70.37
Volume
452,117.946
Open
$65.47
Previous Close
$65.73
Daily Range
$65.03 - $71.25
52-Week Range
$23.65 - $75.50
Estimated Earnings Date
May 7, 2026
CGON News
CGON: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cg Oncology
Industry
Biotechnology
Sector
Health CareEmployees
142
CEO
Arthur Kuan
Website
www.cgoncology.comHeadquarters
Irvine, CA 92618, US
CGON Financials
Key Financial Metrics (TTM)
Gross Margin
-664.82%
Operating Margin
-4238.99%
Net Income Margin
-3682.61%
Return on Equity
-23.33%
Return on Capital
-25.11%
Return on Assets
-16.45%
Earnings Yield
-3.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.80B
Shares Outstanding
88.20M
Volume
452.12K
Avg. Volume
1.02M
Financials (TTM)
Gross Profit
-$33.71M
Operating Income
-$214.96M
EBITDA
-$184.48M
Operating Cash Flow
-$160.01M
Capital Expenditure
-$422.00K
Free Cash Flow
-$160.43M
Cash & ST Invst.
$1.08B
Total Debt
$7.58M
Cg Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.08M
+1982.7%
Gross Profit
-$1.88M
-3713.5%
Gross Margin
-1.73%
N/A
Market Cap
$5.80B
N/A
Market Cap/Employee
$40.83M
N/A
Employees
142
N/A
Net Income
-$60.20M
-74.7%
EBITDA
-$59.36M
-72.4%
Quarterly Fundamentals
Total Cash
$1.08B
+56.3%
Total Debt
$7.58M
+631.2%
Accounts Receivable
$1.28M
+269.6%
Inventory
$1.49M
N/A
Long Term Debt
$6.51M
+733.4%
Short Term Debt
$1.07M
+318.0%
Return on Assets
-16.45%
N/A
Return on Invested Capital
-19.54%
N/A
Free Cash Flow
-$57.25M
-95.4%
Operating Cash Flow
-$56.94M
-94.5%